Alexander A Chang, MD
Internal Medicine · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 12 years
- Graduated 2014
Offices
1 location · Truelight Medical Corporation · 3 clinicians in this group
Hospitals listed: 559279 · California Pacific Medical Center- Van Ness Campus · Chinese Hospital · Marinhealth Medical Center · Mills-Peninsula Medical Center · UCSF Health Hyde Hospital. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chang’s office at (415) 771-4366 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A127376 · Current
Licensed to practise in California · since 2013 · expires 2027-01-31 · Rush Medical College of Rush University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- Chinese HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPatients rate it 3 of 5 · 64% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- UCSF Health Saint Francis HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 61% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.251, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Chinese Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 7 the same, 1 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 104 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.12 (0.64 to 1.61) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 28 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.6 · 71 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 66 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 569 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.44) · 766 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 749 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.34 (0.76 to 5.93) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.13 (0.4 to 3.85) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.3 (0.57 to 4.02) · 93 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.72 (0 to 18.54) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.04 (0.78 to 9.3) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.07 (0.55 to 3.59) · 58 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.12 (0 to 2.33) · 543 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.392 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 111 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 33 · 78 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 16.3 · 64 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 148 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.1 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.1) · 478 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 39 cases | No different | Jan 2024 – Dec 2024 |
What patients said (160 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 68% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 64% |
| Staff "always" explained possible side effects | 57% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for UCSF Health Saint Francis Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.251 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 146 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.41 to 1.26) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 26 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.8 · 52 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.6 · 84 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.2 · 37 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 379 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,255 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,226 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.5 (1.04 to 5.97) · 221 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.37) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.52 to 3.89) · 222 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.17 (0 to 16.08) · 111 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.97 (0.74 to 9.21) · 87 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.2 to 3.23) · 55 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1.32) · 1,068 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 35 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.499 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 55 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 15.7 · 61 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 54 · 84 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.1 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.1 to 18.1) · 87 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.6) · 35 cases | No different | Jan 2024 – Dec 2024 |
What patients said (217 patients answered, 14% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 69% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 68% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 61% |
| Nurses "always" listened carefully | 67% |
| Nurses "always" treated them with courtesy and respect | 79% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 61% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$77,392
Medicare paid this office $77,392 for 165 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 131 | $30,037 | $99 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 87 | $13,543 | $156 |
| Short return visit (20+ min) | 58 | $6,628 | $68 |
| Acupuncture, initial 15 minutes | 12 | $3,445 | $32 |
| Long return visit (40+ min) | 17 | $2,771 | $146 |
See all 11 services
| Return visit (30+ min) | 131 | $30,037 | $99 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 87 | $13,543 | $156 |
| Short return visit (20+ min) | 58 | $6,628 | $68 |
| Acupuncture, initial 15 minutes | 12 | $3,445 | $32 |
| Long return visit (40+ min) | 17 | $2,771 | $146 |
| Acupuncture, each additional 15 minutes | 12 | $2,636 | $24 |
| Influenza vaccine, inactivated | 31 | $2,536 | $82 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 16 | $2,037 | $33 |
| Administration of influenza virus vaccine | 33 | $1,276 | $39 |
| New patient visit (45+ min) | 14 | $1,056 | $75 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $181 | $11 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
165 Original Medicare patients in 2024. Average age 78 · Women 46% · Also on Medicaid 12% · Health risk score 1.03. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 73% · Coronary heart disease 21% · Diabetes 20% · Atrial fibrillation 20% · Chronic kidney disease 18% · Heart failure 13% · Stroke 13% · Cancer 10% · Depression 10% · Dementia 10% · COPD 7%.
The office billed $213,724, Medicare allowed $105,799 and paid $77,392; for 1,073 services of 37 kinds; $2,646 of it was for drugs given in the office and $74,746 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 165 | 1,073 | 78 | 1.03 | $213,724 | $77,392 |
| 2023 | 173 | 741 | 78 | 0.97 | $168,692 | $66,560 |
| 2022 | 209 | 779 | 77 | 1.06 | $180,038 | $77,822 |
| 2021 | 135 | 500 | 76 | 0.96 | $100,794 | $45,862 |
| 2020 | 99 | 276 | 78 | 1.14 | $36,245 | $19,632 |
| 2019 | 28 | 52 | 75 | 1.06 | $5,460 | $3,122 |
| 2018 | 33 | 166 | 71 | 1.12 | $4,678 | $1,763 |
| 2017 | 85 | 805 | 69 | 0.93 | $22,656 | $9,053 |
| 2016 | 68 | 626 | 71 | 0.87 | $18,435 | $7,509 |
| 2015 | 122 | 854 | 74 | 1.09 | $36,796 | $16,378 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Return visit (30+ min) | 161 | $36,515 | $97 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 82 | $12,540 | $153 |
| Short return visit (20+ min) | 44 | $3,942 | $56 |
| Long return visit (40+ min) | 14 | $2,508 | $157 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 27 | $1,966 | $73 |
| New patient visit (45+ min) | 15 | $1,403 | $94 |
| Administration of influenza virus vaccine | 26 | $941 | $36 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 23 | $296 | $12 |
2022: 12 services
| Return visit (30+ min) | 144 | $29,599 | $101 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 84 | $12,924 | $154 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 26 | $7,252 | $279 |
| New patient visit (45+ min) | 58 | $6,411 | $111 |
| Short return visit (20+ min) | 61 | $5,422 | $70 |
| New patient visit (60+ min) | 18 | $3,508 | $195 |
| Telephone medical discussion with physician, 11-20 minutes | 33 | $2,242 | $55 |
| Telephone medical discussion with physician, 21-30 minutes | 16 | $1,330 | $70 |
| Administration of pneumococcal vaccine | 32 | $1,161 | $36 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 16 | $1,124 | $70 |
| Administration of influenza virus vaccine | 23 | $829 | $36 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 17 | $218 | $12 |
2021: 10 services
| Return visit (30+ min) | 86 | $18,897 | $110 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 58 | $9,213 | $159 |
| New patient visit (45+ min) | 34 | $3,613 | $106 |
| Short return visit (20+ min) | 40 | $3,246 | $71 |
| Pneumococcal vaccine, 23-valent | 17 | $2,141 | $126 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 22 | $1,461 | $66 |
| New patient visit (30+ min) | 26 | $640 | $25 |
| Administration of influenza virus vaccine | 27 | $572 | $21 |
| Administration of pneumococcal vaccine | 15 | $318 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 24 | $263 | $11 |
2020: 6 services
| Return visit (30+ min) | 59 | $9,367 | $88 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 24 | $3,364 | $140 |
| Influenza vaccine split virus, preservative free | 35 | $2,134 | $61 |
| Short return visit (20+ min) | 20 | $1,209 | $55 |
| Administration of influenza virus vaccine | 36 | $741 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $163 | $15 |
2019: 3 services
| Return visit (30+ min) | 11 | $1,377 | $92 |
| Influenza vaccine split virus, preservative free | 14 | $768 | $55 |
| Administration of influenza virus vaccine | 14 | $283 | $20 |
2018: 5 services
| Blood test, thyroid stimulating hormone (tsh) | 15 | $325 | $20 |
| Blood test, comprehensive group of blood chemicals | 23 | $307 | $13 |
| Blood test, lipids (cholesterol and triglycerides) | 15 | $243 | $16 |
| Insertion of needle into vein for collection of blood sample | 33 | $112 | $3 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 11 | $103 | $9 |
2017: 16 services
| Blood test, comprehensive group of blood chemicals | 71 | $1,435 | $13 |
| Blood test, thyroid stimulating hormone (tsh) | 54 | $1,423 | $23 |
| Vitamin d-3 level | 21 | $1,075 | $40 |
| Blood test, lipids (cholesterol and triglycerides) | 50 | $742 | $14 |
| Hemoglobin a1c level | 28 | $639 | $13 |
| Insertion of needle into vein for collection of blood sample | 80 | $594 | $3 |
| Blood test, basic group of blood chemicals (calcium, total) | 28 | $498 | $11 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 20 | $428 | $21 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 29 | $387 | $10 |
| Detection test by immunoassay technique for hepatitis b surface antigen | 19 | $278 | $14 |
| Hepatitis b surface antibody measurement | 15 | $231 | $14 |
| Urine microalbumin (protein) level | 20 | $194 | $8 |
| Creatinine level to test for kidney function or muscle injury | 21 | $188 | $7 |
| Thyroxine (thyroid chemical), free | 13 | $182 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $97 | $7 |
| Manual urinalysis test with examination using microscope, automated | 16 | $94 | $4 |
2016: 13 services
| Vitamin d-3 level | 23 | $1,344 | $40 |
| Blood test, comprehensive group of blood chemicals | 50 | $1,059 | $12 |
| Blood test, thyroid stimulating hormone (tsh) | 30 | $763 | $22 |
| Blood test, lipids (cholesterol and triglycerides) | 38 | $659 | $15 |
| Hemoglobin a1c level | 27 | $596 | $13 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 28 | $498 | $10 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 23 | $489 | $21 |
| Insertion of needle into vein for collection of blood sample | 58 | $397 | $3 |
| Blood test, basic group of blood chemicals (calcium, total) | 15 | $229 | $11 |
| Urine microalbumin (protein) level | 20 | $216 | $8 |
| Creatinine level to test for kidney function or muscle injury | 20 | $187 | $7 |
| Detection test by immunoassay technique for hepatitis b surface antigen | 12 | $179 | $14 |
| Manual urinalysis test with examination using microscope, automated | 13 | $72 | $4 |
2015: 16 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $2,860 | $65 |
| Blood test, comprehensive group of blood chemicals | 57 | $1,064 | $13 |
| Blood test, thyroid stimulating hormone (tsh) | 31 | $784 | $22 |
| Blood test, lipids (cholesterol and triglycerides) | 46 | $714 | $14 |
| Vitamin d-3 level | 12 | $671 | $39 |
| Hemoglobin a1c level | 35 | $609 | $13 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 26 | $552 | $21 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 32 | $508 | $10 |
| Insertion of needle into vein for collection of blood sample | 83 | $465 | $3 |
| Blood test, basic group of blood chemicals (calcium, total) | 33 | $398 | $9 |
| Hepatitis b surface antibody measurement | 27 | $387 | $14 |
| Detection test by immunoassay technique for hepatitis b surface antigen | 27 | $372 | $14 |
| Urine microalbumin (protein) level | 25 | $216 | $8 |
| Creatinine level to test for kidney function or muscle injury | 27 | $214 | $7 |
| Manual urinalysis test with examination using microscope, automated | 26 | $139 | $4 |
| Liver enzyme (sgpt), level | 13 | $52 | $4 |
Medicaid work
$45,697 in 2018
Medicaid paid $45,697 for 1,094 billed services this clinician did in 2018, up to 221 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 555 | $45,368 |
| Short return visit (20+ min) | 170 | $329 |
| Skin test; tuberculosis, intradermal | 13 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 102 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 37 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 47 | $0 |
| Return visit (30+ min) | 151 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 19 | $0 |
| 2018 | 1,094 | 8 | 221 | $45,697 |
Drugs they prescribed that Part D paid
$723,011
Pharmacies billed $723,011 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (17 of 5,297) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
4,594 generic and 677 brand-name prescriptions · $723,011 in drug cost · 96 antibiotic prescriptions to 51 people · 16 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 72 | $97,947 | $1,360 |
| Trulicity | 59 | $73,767 | $1,250 |
| Januvia | 48 | $52,896 | $1,102 |
| Rybelsus | 18 | $49,854 | $2,770 |
| Eliquis | 29 | $47,098 | $1,624 |
See all 91 drugs
| Jardiance | 72 | $97,947 | $1,360 |
| Trulicity | 59 | $73,767 | $1,250 |
| Januvia | 48 | $52,896 | $1,102 |
| Rybelsus | 18 | $49,854 | $2,770 |
| Eliquis | 29 | $47,098 | $1,624 |
| Ozempic | 29 | $40,763 | $1,406 |
| Tymlos | 13 | $33,157 | $2,551 |
| Xarelto | 27 | $28,979 | $1,073 |
| Farxiga | 21 | $27,660 | $1,317 |
| Vemlidy | 14 | $20,303 | $1,450 |
| Edarbi | 22 | $10,430 | $474 |
| Trelegy Ellipta | 15 | $9,661 | $644 |
| Anoro Ellipta | 19 | $9,492 | $500 |
| Combivent Respimat | 16 | $7,632 | $477 |
| Atorvastatin | 518 | $5,384 | $10 |
| Tamsulosin | 152 | $3,299 | $22 |
| Metoprolol | 147 | $2,517 | $17 |
| Losartan | 241 | $2,221 | $9 |
| Wixela Inhub | 19 | $2,206 | $116 |
| Alendronate | 86 | $1,982 | $23 |
| Breyna | 13 | $1,935 | $149 |
| Varenicline | 14 | $1,876 | $134 |
| Levothyroxine | 117 | $1,859 | $16 |
| Amlodipine Besylate | 287 | $1,727 | $6 |
| Omeprazole | 116 | $1,690 | $15 |
| Gabapentin | 89 | $1,686 | $19 |
| Lantus | 13 | $1,681 | $129 |
| Famotidine | 115 | $1,663 | $14 |
| Metformin | 159 | $1,436 | $9 |
| Pravastatin | 100 | $1,345 | $13 |
| Fluticasone Propionate | 98 | $1,312 | $13 |
| Albuterol Sulfate Hfa | 33 | $1,222 | $37 |
| Ezetimibe | 34 | $1,208 | $36 |
| Lisinopril | 170 | $1,039 | $6 |
| Colchicine | 15 | $907 | $60 |
| Finasteride | 92 | $843 | $9 |
| Pioglitazone | 26 | $773 | $30 |
| Glipizide | 57 | $673 | $12 |
| Diclofenac | 37 | $673 | $18 |
| Valsartan | 22 | $640 | $29 |
| Fluticasone-Salmeterol | 12 | $614 | $51 |
| Ketoconazole | 48 | $587 | $12 |
| Simvastatin | 111 | $577 | $5 |
| Montelukast | 32 | $563 | $18 |
| Telmisartan | 15 | $556 | $37 |
| Carvedilol | 60 | $533 | $9 |
| Clobetasol Propionate | 26 | $513 | $20 |
| Irbesartan | 23 | $511 | $22 |
| Triamcinolone Acetonide | 57 | $492 | $9 |
| Azelastine | 22 | $490 | $22 |
| Mirtazapine | 21 | $482 | $23 |
| Rosuvastatin | 54 | $429 | $8 |
| Allopurinol | 46 | $416 | $9 |
| Oxybutynin Chloride Er | 21 | $400 | $19 |
| Hydrochlorothiazide | 109 | $384 | $4 |
| Metformin Hcl Er | 38 | $382 | $10 |
| Escitalopram | 23 | $354 | $15 |
| Nitrofurantoin Mono-Macro | 12 | $348 | $29 |
| Pantoprazole | 23 | $325 | $14 |
| Potassium Chloride | 33 | $315 | $10 |
| Ibuprofen | 57 | $290 | $5 |
| Clotrimazole-Betamethasone | 16 | $275 | $17 |
| Metoprolol | 35 | $251 | $7 |
| Atenolol | 40 | $250 | $6 |
| Zolpidem | 45 | $233 | $5 |
| Clopidogrel | 18 | $230 | $13 |
| Naproxen | 23 | $222 | $10 |
| Hydrocortisone | 18 | $217 | $12 |
| Memantine | 14 | $211 | $15 |
| Ciclopirox | 22 | $210 | $10 |
| Amlodipine Besylate-Benazepril | 13 | $198 | $15 |
| Baclofen | 14 | $193 | $14 |
| Furosemide | 50 | $190 | $4 |
| Felodipine Er | 13 | $184 | $14 |
| Hydralazine | 16 | $176 | $11 |
| Mupirocin | 17 | $151 | $9 |
| Lovastatin | 32 | $151 | $5 |
| Triamterene-Hydrochlorothiazid | 28 | $150 | $5 |
| Benazepril | 17 | $138 | $8 |
| Glipizide Er | 26 | $135 | $5 |
| Loperamide | 12 | $128 | $11 |
| Celecoxib | 18 | $126 | $7 |
| Terazosin | 12 | $110 | $9 |
| Sumatriptan | 18 | $94 | $5 |
| Quetiapine | 16 | $84 | $5 |
| Prednisone | 11 | $50 | $5 |
| Azithromycin | 17 | $41 | $2 |
| Donepezil | 25 | $34 | $1 |
| Sildenafil Citrate | 18 | $15 | $1 |
| Sertraline | 13 | $7 | $1 |
| Paxlovid | 14 | $0 | $0 |
Year by year
| 2024 | 5,297 | 400 | 0% (17) | 13% | $723,011 |
| 2023 | 5,208 | 439 | 1% (38) | 12% | $704,362 |
| 2022 | 4,108 | 429 | 1% (32) | 11% | $453,615 |
| 2021 | 2,719 | 320 | 1% (25) | None | $286,667 |
| 2020 | 1,270 | 253 | None | None | $105,927 |
| 2019 | 502 | 133 | None | None | $42,403 |
| 2018 | 711 | 102 | None | None | $50,240 |
| 2017 | 1,447 | 119 | None | None | $80,834 |
| 2016 | 1,148 | 113 | None | None | $72,933 |
| 2015 | 946 | 147 | None | None | $59,077 |
| 2014 | 125 | 34 | None | 13% | $3,906 |
| 2013 | 74 | 19 | None | 19% | $3,424 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 88 drugs
| Trulicity | 54 | $96,816 | $1,793 |
| Jardiance | 54 | $88,071 | $1,631 |
| Januvia | 47 | $59,149 | $1,258 |
| Forteo | 12 | $47,718 | $3,977 |
| Eliquis | 24 | $40,886 | $1,704 |
| Xarelto | 31 | $30,128 | $972 |
| Ozempic | 17 | $26,787 | $1,576 |
| Vemlidy | 13 | $19,294 | $1,484 |
| Lantus | 26 | $13,582 | $522 |
| Edarbi | 24 | $10,933 | $456 |
| Spiriva Respimat | 17 | $9,336 | $549 |
| Atorvastatin | 563 | $8,816 | $16 |
| Wixela Inhub | 37 | $8,400 | $227 |
| Advair Diskus | 17 | $7,986 | $470 |
| Tamsulosin | 151 | $5,109 | $34 |
| Alendronate | 93 | $4,547 | $49 |
| Lantus Solostar | 14 | $3,854 | $275 |
| Metoprolol | 134 | $3,796 | $28 |
| Amlodipine Besylate | 318 | $3,619 | $11 |
| Losartan | 182 | $3,049 | $17 |
| Ezetimibe | 33 | $2,688 | $81 |
| Famotidine | 105 | $2,679 | $26 |
| Levothyroxine | 100 | $2,300 | $23 |
| Metformin | 153 | $2,101 | $14 |
| Pravastatin | 94 | $2,024 | $22 |
| Gabapentin | 70 | $1,909 | $27 |
| Colchicine | 15 | $1,720 | $115 |
| Lisinopril | 170 | $1,644 | $10 |
| Diclofenac | 72 | $1,642 | $23 |
| Ketoconazole | 64 | $1,578 | $25 |
| Oxybutynin Chloride Er | 34 | $1,563 | $46 |
| Fluticasone Propionate | 86 | $1,538 | $18 |
| Irbesartan | 38 | $1,515 | $40 |
| Omeprazole | 95 | $1,495 | $16 |
| Carvedilol | 71 | $1,362 | $19 |
| Pioglitazone | 29 | $1,330 | $46 |
| Finasteride | 82 | $1,322 | $16 |
| Albuterol Sulfate Hfa | 35 | $1,238 | $35 |
| Sildenafil Citrate | 31 | $1,234 | $40 |
| Simvastatin | 120 | $1,152 | $10 |
| Potassium Chloride | 25 | $974 | $39 |
| Valsartan | 14 | $953 | $68 |
| Baclofen | 14 | $922 | $66 |
| Clobetasol Propionate | 14 | $863 | $62 |
| Allopurinol | 49 | $825 | $17 |
| Hydrochlorothiazide | 105 | $787 | $7 |
| Clopidogrel | 32 | $750 | $23 |
| Montelukast | 45 | $729 | $16 |
| Felodipine Er | 12 | $720 | $60 |
| Telmisartan | 15 | $666 | $44 |
| Memantine | 17 | $663 | $39 |
| Atenolol | 57 | $653 | $11 |
| Pantoprazole | 34 | $637 | $19 |
| Quetiapine | 16 | $556 | $35 |
| Triamterene-Hydrochlorothiazid | 40 | $541 | $14 |
| Glipizide | 49 | $539 | $11 |
| Zolpidem | 45 | $536 | $12 |
| Rosuvastatin | 38 | $531 | $14 |
| Azelastine | 15 | $508 | $34 |
| Benazepril | 24 | $481 | $20 |
| Hydrocortisone | 17 | $476 | $28 |
| Minocycline | 13 | $467 | $36 |
| Escitalopram | 18 | $452 | $25 |
| Metoprolol | 38 | $445 | $12 |
| Triamcinolone Acetonide | 53 | $441 | $8 |
| Sucralfate | 20 | $434 | $22 |
| Furosemide | 51 | $422 | $8 |
| Ciclopirox | 13 | $410 | $32 |
| Mirtazapine | 20 | $398 | $20 |
| Lovastatin | 34 | $393 | $12 |
| Propranolol | 15 | $390 | $26 |
| Paxlovid (Eua) | 35 | $367 | $10 |
| Lorazepam | 27 | $362 | $13 |
| Metformin Hcl Er | 26 | $340 | $13 |
| Hydroxyzine | 11 | $333 | $30 |
| Ibuprofen | 36 | $326 | $9 |
| Hydrocodone-Acetaminophen | 18 | $297 | $16 |
| Losartan-Hydrochlorothiazide | 21 | $293 | $14 |
| Naproxen | 19 | $264 | $14 |
| Irbesartan-Hydrochlorothiazide | 11 | $250 | $23 |
| Trazodone | 19 | $204 | $11 |
| Cyclobenzaprine | 13 | $187 | $14 |
| Mupirocin | 13 | $156 | $12 |
| Sumatriptan | 18 | $143 | $8 |
| Donepezil | 21 | $128 | $6 |
| Azithromycin | 17 | $83 | $5 |
| Tramadol | 14 | $75 | $5 |
| Sertraline | 12 | $44 | $4 |
2022: 74 drugs
| Trulicity | 36 | $66,807 | $1,856 |
| Jardiance | 33 | $49,351 | $1,495 |
| Januvia | 26 | $41,500 | $1,596 |
| Eliquis | 20 | $33,208 | $1,660 |
| Ozempic | 18 | $25,531 | $1,418 |
| Xarelto | 30 | $19,733 | $658 |
| Farxiga | 14 | $16,425 | $1,173 |
| Lantus | 27 | $14,636 | $542 |
| Atorvastatin | 444 | $5,010 | $11 |
| Tamsulosin | 133 | $4,718 | $35 |
| Lantus Solostar | 13 | $4,040 | $311 |
| Gabapentin | 64 | $2,844 | $44 |
| Metoprolol | 104 | $2,643 | $25 |
| Wixela Inhub | 14 | $2,574 | $184 |
| Albuterol Sulfate Hfa | 21 | $1,942 | $92 |
| Metformin | 154 | $1,854 | $12 |
| Irbesartan | 32 | $1,818 | $57 |
| Losartan | 140 | $1,655 | $12 |
| Alendronate | 72 | $1,648 | $23 |
| Levothyroxine | 77 | $1,634 | $21 |
| Pravastatin | 82 | $1,561 | $19 |
| Diclofenac | 56 | $1,478 | $26 |
| Famotidine | 85 | $1,477 | $17 |
| Amlodipine Besylate | 225 | $1,373 | $6 |
| Omeprazole | 88 | $1,355 | $15 |
| Fluticasone Propionate | 71 | $1,286 | $18 |
| Lisinopril | 156 | $1,254 | $8 |
| Potassium Chloride | 33 | $1,213 | $37 |
| Oxybutynin Chloride Er | 18 | $1,019 | $57 |
| Baclofen | 11 | $964 | $88 |
| Memantine | 11 | $888 | $81 |
| Rosuvastatin | 31 | $885 | $29 |
| Felodipine Er | 13 | $722 | $56 |
| Allopurinol | 43 | $692 | $16 |
| Ketoconazole | 26 | $690 | $27 |
| Telmisartan | 12 | $677 | $56 |
| Simvastatin | 88 | $663 | $8 |
| Valacyclovir | 15 | $661 | $44 |
| Finasteride | 46 | $632 | $14 |
| Montelukast | 37 | $631 | $17 |
| Triamcinolone Acetonide | 46 | $598 | $13 |
| Carvedilol | 52 | $595 | $11 |
| Valsartan | 16 | $558 | $35 |
| Mirtazapine | 23 | $485 | $21 |
| Hydrochlorothiazide | 71 | $459 | $6 |
| Furosemide | 69 | $443 | $6 |
| Metformin Hcl Er | 30 | $443 | $15 |
| Glipizide | 40 | $442 | $11 |
| Clopidogrel | 21 | $429 | $20 |
| Pantoprazole | 26 | $394 | $15 |
| Lovastatin | 26 | $385 | $15 |
| Atenolol | 40 | $366 | $9 |
| Naproxen | 20 | $352 | $18 |
| Triamterene-Hydrochlorothiazid | 22 | $329 | $15 |
| Hydralazine | 11 | $317 | $29 |
| Zolpidem | 31 | $300 | $10 |
| Benazepril | 21 | $294 | $14 |
| Pioglitazone | 19 | $293 | $15 |
| Escitalopram | 16 | $293 | $18 |
| Nitrofurantoin Mono-Macro | 14 | $286 | $20 |
| Metoprolol | 28 | $264 | $9 |
| Losartan-Hydrochlorothiazide | 12 | $260 | $22 |
| Ibuprofen | 26 | $214 | $8 |
| Sildenafil Citrate | 11 | $197 | $18 |
| Cyclobenzaprine | 16 | $196 | $12 |
| Paxlovid (Eua) | 20 | $181 | $9 |
| Hydroxyzine | 12 | $150 | $12 |
| Lorazepam | 16 | $114 | $7 |
| Trazodone | 15 | $109 | $7 |
| Azithromycin | 12 | $95 | $8 |
| Sumatriptan | 13 | $71 | $5 |
| Tramadol | 14 | $68 | $5 |
| Donepezil | 11 | $66 | $6 |
| Sertraline | 12 | $63 | $5 |
2021: 50 drugs
| Januvia | 26 | $36,772 | $1,414 |
| Eliquis | 25 | $31,894 | $1,276 |
| Jardiance | 25 | $30,292 | $1,212 |
| Trulicity | 14 | $23,325 | $1,666 |
| Xarelto | 14 | $12,468 | $891 |
| Ozempic | 11 | $10,958 | $996 |
| Lantus | 17 | $7,243 | $426 |
| Lantus Solostar | 19 | $4,724 | $249 |
| Atorvastatin | 286 | $4,636 | $16 |
| Alphagan P | 15 | $2,792 | $186 |
| Metoprolol | 53 | $1,860 | $35 |
| Diclofenac | 70 | $1,824 | $26 |
| Tamsulosin | 65 | $1,639 | $25 |
| Gabapentin | 51 | $1,444 | $28 |
| Losartan | 97 | $1,242 | $13 |
| Albuterol Sulfate Hfa | 14 | $1,168 | $83 |
| Pravastatin | 50 | $1,132 | $23 |
| Felodipine Er | 11 | $1,061 | $96 |
| Levothyroxine | 44 | $1,030 | $23 |
| Famotidine | 59 | $911 | $15 |
| Metformin | 101 | $904 | $9 |
| Ketoconazole | 33 | $882 | $27 |
| Omeprazole | 57 | $849 | $15 |
| Lisinopril | 103 | $769 | $7 |
| Amlodipine Besylate | 144 | $732 | $5 |
| Rosuvastatin | 23 | $658 | $29 |
| Ciclopirox | 19 | $656 | $35 |
| Alendronate | 75 | $636 | $8 |
| Fluticasone Propionate | 43 | $626 | $15 |
| Pantoprazole | 34 | $507 | $15 |
| Metformin Hcl Er | 36 | $482 | $13 |
| Carvedilol | 37 | $471 | $13 |
| Allopurinol | 32 | $455 | $14 |
| Simvastatin | 57 | $405 | $7 |
| Finasteride | 22 | $339 | $15 |
| Hydrochlorothiazide | 38 | $322 | $8 |
| Montelukast | 20 | $292 | $15 |
| Glipizide | 24 | $281 | $12 |
| Furosemide | 46 | $281 | $6 |
| Triamcinolone Acetonide | 29 | $259 | $9 |
| Mirtazapine | 15 | $258 | $17 |
| Atenolol | 29 | $250 | $9 |
| Losartan-Hydrochlorothiazide | 15 | $240 | $16 |
| Benazepril | 22 | $214 | $10 |
| Sumatriptan | 11 | $143 | $13 |
| Zolpidem | 21 | $137 | $7 |
| Ibuprofen | 28 | $134 | $5 |
| Lovastatin | 13 | $133 | $10 |
| Trazodone | 16 | $129 | $8 |
| Metoprolol | 16 | $88 | $5 |
2020: 31 drugs
| Jardiance | 18 | $19,742 | $1,097 |
| Brilinta | 11 | $4,438 | $403 |
| Atorvastatin | 138 | $2,971 | $22 |
| Diclofenac | 55 | $1,492 | $27 |
| Gabapentin | 32 | $1,384 | $43 |
| Metoprolol | 30 | $693 | $23 |
| Losartan | 50 | $611 | $12 |
| Pravastatin | 17 | $561 | $33 |
| Tamsulosin | 33 | $543 | $16 |
| Fluticasone Propionate | 30 | $542 | $18 |
| Famotidine | 39 | $484 | $12 |
| Ketoconazole | 16 | $391 | $24 |
| Levothyroxine | 12 | $373 | $31 |
| Omeprazole | 34 | $359 | $11 |
| Pantoprazole | 19 | $338 | $18 |
| Amlodipine Besylate | 60 | $330 | $6 |
| Metformin | 41 | $302 | $7 |
| Alendronate | 29 | $284 | $10 |
| Triamcinolone Acetonide | 23 | $254 | $11 |
| Ciclopirox | 12 | $251 | $21 |
| Lisinopril | 34 | $243 | $7 |
| Montelukast | 16 | $213 | $13 |
| Benazepril | 20 | $211 | $11 |
| Losartan-Hydrochlorothiazide | 12 | $152 | $13 |
| Hydrochlorothiazide | 15 | $152 | $10 |
| Ibuprofen | 23 | $124 | $5 |
| Simvastatin | 18 | $119 | $7 |
| Metoprolol | 11 | $114 | $10 |
| Metformin Hcl Er | 13 | $97 | $7 |
| Carvedilol | 11 | $90 | $8 |
| Naproxen | 12 | $40 | $3 |
2019: 13 drugs
| Atorvastatin | 28 | $1,527 | $55 |
| Tamsulosin | 11 | $834 | $76 |
| Omeprazole | 12 | $584 | $49 |
| Ketoconazole | 14 | $571 | $41 |
| Lisinopril | 25 | $514 | $21 |
| Amlodipine Besylate | 31 | $446 | $14 |
| Hydrochlorothiazide | 21 | $406 | $19 |
| Fluticasone Propionate | 13 | $393 | $30 |
| Diclofenac | 11 | $385 | $35 |
| Pravastatin | 11 | $382 | $35 |
| Losartan | 17 | $287 | $17 |
| Montelukast | 12 | $259 | $22 |
| Triamcinolone Acetonide | 16 | $211 | $13 |
2018: 21 drugs
| Advair Diskus | 12 | $5,467 | $456 |
| Combivent Respimat | 14 | $5,311 | $379 |
| Atorvastatin | 77 | $1,506 | $20 |
| Rosuvastatin | 15 | $865 | $58 |
| Pravastatin | 32 | $864 | $27 |
| Tamsulosin | 17 | $697 | $41 |
| Levothyroxine | 14 | $480 | $34 |
| Metoprolol | 16 | $460 | $29 |
| Alendronate | 42 | $350 | $8 |
| Fluticasone Propionate | 20 | $338 | $17 |
| Finasteride | 16 | $272 | $17 |
| Losartan | 32 | $258 | $8 |
| Gabapentin | 13 | $225 | $17 |
| Omeprazole | 23 | $207 | $9 |
| Amlodipine Besylate | 38 | $170 | $4 |
| Metformin | 19 | $161 | $8 |
| Triamcinolone Acetonide | 13 | $121 | $9 |
| Famotidine | 16 | $118 | $7 |
| Hydrochlorothiazide | 21 | $94 | $4 |
| Metformin Hcl Er | 14 | $91 | $7 |
| Lisinopril | 13 | $70 | $5 |
2017: 37 drugs
| Symbicort | 12 | $3,711 | $309 |
| Atorvastatin | 129 | $2,724 | $21 |
| Pravastatin | 60 | $1,884 | $31 |
| Tamsulosin | 29 | $1,541 | $53 |
| Voltaren | 27 | $1,411 | $52 |
| Levothyroxine | 33 | $1,064 | $32 |
| Rosuvastatin | 13 | $963 | $74 |
| Gabapentin | 32 | $963 | $30 |
| Valsartan | 19 | $928 | $49 |
| Ketoconazole | 27 | $831 | $31 |
| Metoprolol | 22 | $685 | $31 |
| Fluticasone Propionate | 48 | $654 | $14 |
| Finasteride | 26 | $532 | $20 |
| Losartan | 67 | $479 | $7 |
| Amlodipine Besylate | 67 | $476 | $7 |
| Alendronate | 50 | $428 | $9 |
| Omeprazole | 35 | $401 | $11 |
| Metformin | 37 | $337 | $9 |
| Allopurinol | 13 | $330 | $25 |
| Triamcinolone Acetonide | 38 | $327 | $9 |
| Isoniazid | 20 | $317 | $16 |
| Hydrochlorothiazide | 55 | $304 | $6 |
| Donepezil | 14 | $264 | $19 |
| Famotidine | 27 | $242 | $9 |
| Metformin Hcl Er | 22 | $224 | $10 |
| Pantoprazole | 11 | $208 | $19 |
| Lovastatin | 11 | $173 | $16 |
| Naproxen | 15 | $163 | $11 |
| Lisinopril | 25 | $155 | $6 |
| Terazosin | 13 | $141 | $11 |
| Ibu | 25 | $118 | $5 |
| Simvastatin | 13 | $117 | $9 |
| Polyethylene Glycol 3350 | 14 | $110 | $8 |
| Glipizide | 13 | $109 | $8 |
| Benazepril | 11 | $93 | $8 |
| Lactulose | 12 | $42 | $3 |
| Metoprolol | 11 | $32 | $3 |
2016: 30 drugs
| Januvia | 15 | $15,853 | $1,057 |
| Entecavir | 15 | $15,191 | $1,013 |
| Zostavax | 13 | $3,045 | $234 |
| Atorvastatin | 122 | $2,138 | $18 |
| Tamsulosin | 23 | $1,492 | $65 |
| Pravastatin | 32 | $1,257 | $39 |
| Voltaren | 14 | $692 | $49 |
| Levothyroxine | 25 | $634 | $25 |
| Valsartan | 13 | $616 | $47 |
| Metoprolol | 29 | $533 | $18 |
| Amlodipine Besylate | 76 | $466 | $6 |
| Losartan | 48 | $428 | $9 |
| Alendronate | 57 | $414 | $7 |
| Omeprazole | 28 | $324 | $12 |
| Fluticasone Propionate | 32 | $310 | $10 |
| Gabapentin | 16 | $304 | $19 |
| Hydrochlorothiazide | 59 | $288 | $5 |
| Metformin | 43 | $270 | $6 |
| Diltiazem 24hr Er | 13 | $228 | $18 |
| Isoniazid | 13 | $212 | $16 |
| Triamcinolone Acetonide | 22 | $199 | $9 |
| Finasteride | 13 | $149 | $11 |
| Naproxen | 21 | $124 | $6 |
| Simvastatin | 13 | $118 | $9 |
| Ibuprofen | 23 | $116 | $5 |
| Lovastatin | 18 | $104 | $6 |
| Glipizide | 16 | $98 | $6 |
| Lisinopril | 17 | $91 | $5 |
| Atenolol | 18 | $85 | $5 |
| Lactulose | 11 | $33 | $3 |
2015: 24 drugs
| Zostavax | 13 | $2,953 | $227 |
| Atorvastatin | 92 | $2,662 | $29 |
| Pravastatin | 19 | $1,128 | $59 |
| Proair Hfa | 12 | $1,105 | $92 |
| Tamsulosin | 13 | $873 | $67 |
| Voltaren | 16 | $741 | $46 |
| Metoprolol | 28 | $538 | $19 |
| Losartan | 44 | $511 | $12 |
| Gabapentin | 24 | $423 | $18 |
| Metformin | 42 | $370 | $9 |
| Amlodipine Besylate | 37 | $363 | $10 |
| Ketoconazole | 13 | $343 | $26 |
| Alendronate | 26 | $298 | $11 |
| Omeprazole | 20 | $283 | $14 |
| Fluticasone Propionate | 23 | $279 | $12 |
| Hydrochlorothiazide | 40 | $247 | $6 |
| Ibuprofen | 27 | $204 | $8 |
| Glipizide | 16 | $157 | $10 |
| Triamcinolone Acetonide | 21 | $142 | $7 |
| Lovastatin | 14 | $129 | $9 |
| Atenolol | 14 | $91 | $7 |
| Azithromycin | 14 | $87 | $6 |
| Naproxen | 14 | $74 | $5 |
| Lisinopril | 18 | $71 | $4 |
2014: 1 drug
| Fenofibrate | 11 | $422 | $38 |
Money from drug and device companies
$335 in 2025
| 2025 | 5 | 15 | None | $335 |
| 2024 | 6 | 12 | None | $353 |
| 2023 | 1 | 1 | None | $19 |
| 2022 | 1 | 1 | None | $30 |
| 2021 | 4 | 4 | None | $214 |
| 2020 | 10 | 42 | None | $854 |
| 2019 | 10 | 27 | None | $424 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Airsupra | $205 | 2 payments
|
| Lilly USA | Mounjaro | $54 | 2 payments
|
| Exact Sciences | None | $31 | 1 payment
|
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $28 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $17 | 1 payment
|
See all 7 published payments
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-12-11 | Jardiance | $17 |
| Edwards Lifesciences | Meals · 2025-11-11 | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $28 |
| Exact Sciences | Meals · 2025-10-31 | None | $31 |
| Lilly USA | Meals · 2025-09-08 | Mounjaro | $27 |
| Lilly USA | Meals · 2025-07-14 | Mounjaro | $27 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-20 | Airsupra | $125 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-11 | Airsupra | $80 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $353
| Lilly USA | Mounjaro | $207 | 5 payments
|
| Novo Nordisk | Ozempic | $44 | 2 payments
|
| Pfizer | Paxlovid | $40 | 2 payments
|
| Merck Sharp & Dohme | Gardasil | $26 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $21 | 1 payment
|
| Artivion | Vascular | $15 | 1 payment
|
2023: $19
| GlaxoSmithKline | Arexvy | $19 | 1 payment
|
2022: $30
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $30 | 1 payment
|
2021: $214
| SPR Therapeutics | Sprint Pns System | $154 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $24 | 1 payment
|
| Pfizer | Prevnar 13 | $21 | 1 payment
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $16 | 1 payment
|
2020: $854
| Janssen Pharmaceuticals | Xarelto | $248 | 12 payments
|
| Amarin Pharma | Vascepa | $185 | 12 payments
|
| Lilly USA | Trulicity | $70 | 3 payments
|
| Pfizer | Prevnar 13 | $69 | 3 payments
|
| Amgen | Evenity | $67 | 3 payments
|
| GlaxoSmithKline | Pediarix | $65 | 3 payments
|
| AbbVie | Creon | $44 | 2 payments
|
| Novo Nordisk | Ozempic | $37 | 2 payments
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $36 | 1 payment
|
| Gilead Sciences | None | $32 | 1 payment
|
2019: $424
| Gilead Sciences | None | $152 | 11 payments
|
| Pfizer | Chantix | $70 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $42 | 3 payments
|
| Amarin Pharma | Vascepa | $41 | 2 payments
|
| Merck Sharp & Dohme | Januvia | $28 | 2 payments
|
| Allergan | Avycaz | $24 | 2 payments
|
| Lilly USA | Glyxambi | $21 | 1 payment
|
| AbbVie | Creon | $16 | 1 payment
|
| Sanofi Pasteur | Fluzone Quadrivalent | $15 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $14 | 1 payment
|
Professional record
- NPI
- 1225356231
- Licence
- CA A127376California A127376: Current · expires 2027-01-31
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X); Pediatrics (208000000X)
- Mailing address
- 909 Hyde St Ste 230, San Francisco, CA, 94109
- NPI first listed
- 2010-05-14
- NPI last updated
- 2023-07-27
- NPI record certified
- 2023-07-27
This is when the NPI record was last certified, not a medical board exam.